Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
Monoclonal
IgG1, kappa
1H7
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
Monoclonal
IgG1, kappa
1C2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
Monoclonal
IgG1, kappa
2B9
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
Monoclonal
IgG1, kappa
2F1
Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, IF, Neutralization
Mouse
Monoclonal
IgG2a, kappa
G2
SARS-CoV-2 (2019-nCoV)
Blocking, ELISA
Mouse
Monoclonal
IgG2a, kappa
D31
SARS-CoV-2 (2019-nCoV)
ELISA, Neutralization
Mouse
Monoclonal
IgG2a, kappa
28D9
Middle East respiratory syndrome-related coronavirus (MERS-CoV)
ELISA, Neutralization
Mouse
Monoclonal
IgG2a, kappa
1.6C7
SARS-CoV-2 (2019-nCoV)
ELISA, Neutralization
Mouse
Monoclonal
IgG2a, kappa
18H2
Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, WB
Mouse
Monoclonal
IgG2a, kappa
AT2F7